The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of trifluridine/tipiracil, irinotecan, and bevacizumab in pretreated metastatic colorectal cancer (TABAsCO).
 
Medhavi Gupta
No Relationships to Disclose
 
Christos Fountzilas
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca
 
Namrata Vijayvergia
Research Funding - Bayer; Bayer; Bayer; Bayer; Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst)
 
Kristopher Attwood
No Relationships to Disclose
 
Howard S. Hochster
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Bayer; Bayer; Bayer; Bayer; Exelixis; Exelixis; Exelixis; Exelixis; Genentech; Genentech; Genentech; Genentech
 
Sarbajit Mukherjee
Research Funding - Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst)
 
Renuka V. Iyer
Honoraria - Ipsen; Ipsen; Ipsen; Ipsen
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Eisai; Eisai; Eisai; Eisai; Ipsen; Ipsen; Ipsen; Ipsen; Lexicon; Lexicon; Lexicon; Lexicon; Merck; Merck; Merck; Merck; Novartis; Novartis; Novartis; Novartis; Novartis; Novartis; Novartis; Novartis
Research Funding - Cleveland BioLabs (Inst); Cleveland BioLabs (Inst); Cleveland BioLabs (Inst); Cleveland BioLabs (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Patrick McKay Boland
Honoraria - Boston Biomedical; Boston Biomedical; Boston Biomedical; Boston Biomedical
Consulting or Advisory Role - Merrimack; Merrimack; Merrimack; Merrimack; Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical
Research Funding - Advaxis (Inst); Advaxis (Inst); Advaxis (Inst); Advaxis (Inst); Athenex (Inst); Athenex (Inst); Athenex (Inst); Athenex (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merrimack (Inst); Merrimack (Inst); Merrimack (Inst); Merrimack (Inst); Theradiag (Inst); Theradiag (Inst); Theradiag (Inst); Theradiag (Inst)